drugset / Trial / NCT01597492
A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the impact of belimumab on immune response to pneumococcal vaccine in subjects with Systemic Lupus Erythematosus (SLE).
Timeline
- Start
- 2012-05-31
- Primary completion
- 2015-09-01
- Completion
- 2015-09-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Prevnar 13 | Vaccine | — | — |
| Background | Belimumab | Monoclonal antibody | 10 mg/kg | Intravenous |